Table 3.
Laboratory results of different patient groups.
| COVID-19 pneumonia | Community acquired pneumonia | COVID-19 ARDS | Sepsis ARDS | |
|---|---|---|---|---|
| Lactate (mmol/L) | 1.1 (1.0 - 1.4)3,4 | 1.8 (1.6 - 2.0) | 2.7 (1.6 - 4.0) | |
| Procalcitonin (ng/ml) | 0 (0 - 0.25)3,4 | 0.18 (0.14 - 0.62)4 | 0.90 (0.48 - 0.93)4 | 4.73 (2.22 - 9.40) |
| Leukocyte count (G/l) | 6.68 (3.83 - 11.00)4 | 9.03 (6.85 - 12.50) | 7.92 (7.35 - 12.55) | 14.60 (8.21 - 18.53) |
| C-reactive protein (mg/dl) | 6.2 (2.1 - 10.8)3 | 11.8 (2.4 - 19.1)4 | 22.7 (14.2 - 26.8) | 22.0 (15.7 - 31.1) |
| Interleukin-6 (pg/ml) | 25 (17 - 102) 3,4 | 12 (0 - 29) 3,4 | 492 (247 - 600) | 236 (97 - 1762) |
| Serum Creatinine (mg/dl) | 0.9 (0.8 - 1.0)2,4 | 1.2 (1.1 - 1.6) | 1.1 (1.0 - 1.3) | 1.4 (0.8 - 2.0) |
| Urea (mg/dl) | 26 (23 - 30)4 | 40 (27 - 75) 3 | 19 (14 - 28)4 | 53 (38 - 80) |
| Progranulin (ng/ml) | 71 (55 - 101)2,4 | 37 (34 - 41)3,4 | 85 (73 - 92)4 | 48 (36 - 72) |
Data are median and interquartile range (P25-P75).
P < 0.05 compared to: 2Community acquired pneumonia; 3COVID-19 ARDS; 4Sepsis ARDS. Statistical tests used: Kruskal-Wallis test and Dunn’s test for multiple comparisons.